Denali Therapeutics (NASDAQ:DNLI – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.68) EPS for the quarter, missing the consensus estimate of ($0.51) by ($0.17), FiscalAI reports. The company had revenue of $3.60 million during the quarter, compared to analysts’ expectations of $2.15 million. During the same quarter in the [...]
Earnings watchlistnews Aug 8, 2026